National Institutes of Health
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
About This Grant
The NICHD Small Research Grant Program (R03Basic Experimental Studies with HumansRequired) supports clinical trials that fall within the NICHD mission and also meet the criteria for basic science experimental studies involving humans (BESH), referred to in NOT-OD-18-212 as prospective basic science studies involving human participants. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this NOFO include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind.
Who Can Apply
Focus Areas
Additional Details
- CFDA / ALN Number
- 93.865
- Program Title
- Child Health and Human Development Extramural Research
- Estimated Total Funding
- Up to $50K
- Source
- Grants.gov · View original listing
Similar Grants
Center for Medicare and Medicaid Services
Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence
Up to $3.3MDue in 7 days — May 15, 2026Centers for Disease Control and Prevention - ERA
Occupational Safety and Health Education and Research Centers (T42)
$4.5M – $9MDue October 26, 2028National Institutes of Health
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
Due May 8, 2027National Institutes of Health
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
Due June 1, 2027National Institutes of Health
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Due November 18, 2026National Institutes of Health
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Due January 7, 2028